Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Setting up nicely here!! Nice to see some publicity too!
Message in reply to:
From that article…
”…Huxtable said, another medication that hasn’t gotten FDA approval is being used to treat COVID-19 patients. Drock signed a special release so his wife could receive the drug Brilacidin, he told Nutt.
But, unlike Ivermectin, the FDA has allowed the drug to be used in clinical trials with hospitalized COVID-19 patients.”
It’s good to see BrilAcidin mentioned to casually. What’s shocking if the obvious organized resistance to ivermectin which has been prescribed a billion+ times for human use. Oh, we don’t want to harm anyone! Meanwhile the poor lady has collapsed lungs and is dying.
How many people in India died from use of ivermectin?
We’re living in the medical twilight zone. Vaccines aren’t working but everyone must get vaccinated. Doctors say ivermectin is effective in certain conditions. Aaagh! Ban them! We can’t let anyone hear that.
Good grief.
$IBIO daily coming in for the pinch. Maybe it'll recover before their meeting.
$IBIO daily chart
Nebuchadnezzar called it right.
I appreciate your comment. I have to admit there are the traditional reasons for buying stocks that needs to be a backbone base. Fundamentals have become unfairly secondary in the last 10 plus years being misused as a miniscule temporary play based on a chart that is inconsiderate of how a true stock deserves to grow. Swing traders and daytrafers have developed a deafness of this so to speak. I think the belief is that if a company continues to grow, it'll leave us swing traders in the dust.
Best of luck.
.2302 here, looking to bust a move into the. 30's. Good data comes out this'll be a MAJOR bagger.
Trip and rip through the double top of .255 then rip through back into the .30's.
Let's see it happen Leo!!!
$IPIX daily
$ATHX $1.33 pinch time. Ungreedy target of 1.50.
ATHX daily
One day closer to data folks!!!!
$IPIX
Form 3's building their positions. I'm thinking I'm not the only one thinking this'll be breaking out in the near term.
5.86 high today likely from Cramer's mention. I'm not selling anymore.
$IPIX STARTS WITH A 10 BAGGER!!! I like that idea!
Everything's the same until it's not.
Still waiting on data from a double blind. I'm thinking Leo just releases top line data in a killer PR.
And not a peep until then would be just fine by me.
Everyone's opinion about how we've gotten as far as we have with Leo's managing to spend as little as he has won't matter when BP starts knocking. We just need the data to prove him right.
Good luck folks!!
With CDEL sitting in the .25's waiting we just may see our Friday surges start back up again. Bring it Leo!!
Message in reply to:
Let’s get there and then re-evaluate. Right now we’re 10% of that amount so need to go up ten times from here. It can happen but we have almost five times the number of shares out since time we went to $4.93. We’ll need good news on Phase 2 results, which I have no doubt we’ll get, but we’ll also need good PR and for people that matter to know about the results and what it means. This is an area of uncertainty.
Go IPIX!
ATHX 1.32 Long 1.31.
ATHX dail
Very well put Pete. I agree as well. Of course. If brilacidin sticks and impresses, IPIX should reap the rewards. No doubt about it!
Message in reply to:
I totally agree with what you wrote in that if a BP had offered Leo a proper offer years ago that had a significant increase in royatly percentage as B and K each earned commerciality and grew revenues, thus earning both sides a lot of money and equal risk, that Leo would and should have taken it.
But I believe no BP came forward because the play book always has been the startup bio only gets mere pennies on the dollar at best.
Offers were so meager or lacking that Leo could not take any in good faith to shareholders. Thus we are now at where we are at.
Am I disappointed in the resulting dilution over the years, yes, but they were necessary IMO and Leo did well to keep them below 500MM. What really galled me in your post was saying Leo has been playing the company for his salary and willing to sell out us stockholders for his personal gain. That is the crock of which I spoke.
Now we find ourselves in a position where IPIX has taken ALL THE RISKS and brought Brilacidin to the brink of MASSIVE revenues in the next few years. Thus, I feel IPIX should receive the lion's share of the revenues, not the scraps.
I want Leo to make them pay thru the nose. They were too stupid to realize the value of B, too bad for them, now they pay handsomely to have any part of the platform.
Just a couple notes. May be worth tracking.
ATHX 1.32. Pinch radar reminder. This is right about where I start accumulating.
ATHX daily
SONN .6311 delisting notice, has until April 2022. Thinking they won't have an issue with that soon. Month or 2 tops imo.
SNGX .99 is looking pretty good to me.
IBIO .944 starting to take shape.
I have more but it's early and I need more coffee.
Happy Friday!
Shorts have been waiting for them to get their letter from NASDAQ. Now that they got it, stand by. Any decent dip is going into my coffers for when this short squeezes back over the $$ and maybe even quadruples.
https://ih.advfn.com/stock-market/NASDAQ/sonnet-biotherapeutics-SONN/stock-news/86244313/current-report-filing-8-k
It really is this easy.
IMO of course.
Didn't think LXRX would push through. New HOD 5.58. Looking good.
Added some IBIO .93's. Like the way it's setting up for a potential pinch. We'll see if I'm too early calling it.
IBIO daily
Looking good. 20dma crossing the 50dma. 200 dma is $4.19.
EYEG daily.
Next resistance by the weekly is thru the 1.70's imo.
https://finviz.com/quote.ashx?t=DYNT&ty=c&ta=0&p=w
DYNT daily is actually looking pretty good.
Best to all.
$DYNT
Vaccine from Soligenix Could Accelerate Global Recovery from COVID-19 Pandemic
If there were ever a better time for this article I can't think of it. Just after I put the bug out there, not that it wasn't already in BP's ear, this article comes out.
https://finance.yahoo.com/news/vaccine-soligenix-could-accelerate-global-123000682.html
Just awesome!! Just awesome I say!! Bring on the deals!!!
Message in reply to:
All big Pharma will compete for SNGX's ability to transport without temp control...
SNGX definitely "advertising" with so many recent PRs & updates. Which is great..
GLTA
Thanks Citrati for the kind words. Always good to get other opinions and visualizations when looking at charts. And I consider you in my top 5 chart analysts! Top 2 (you and 123Tom really) even since I haven't seen a few that I follow around anymore. Maybe they're already on their own island somewhere.
I took the 2.40 at a glance from the daily to simply cover the gap up last Friday. Not even sure I can recall how I found RCAT since it wasn't on any of my watchlists. But it was moving on price and volume so I did my thing with a quick flip and decided to keep this one on my list rather than just moving on. Though it's a holding company their subsidiaries are quite interesting. I'm still looking to do some more DD.
The lines from the weekly are a bit different than the RCAT daily chart showing closer to the 2.50 mark. But as a swing trader, if I see something starting to set up I'm not going to sweat buying a little early and missing the bottom. Especially if I think the stock has solid potential. I just keep nibbling until the bottom proves itself. But, as we know, news can change the technical side at any moment.
Cheers and be well & green!!
Cramer said 5.90 lol. See if it gets there.
https://realmoney.thestreet.com/investing/take-a-pass-on-lexicon-pharmaceuticals-for-now-15790582?puc=yahoo&cm_ven=YAHOO
I took off a few shares on LXRX this morning during pre-market in the 5.30's. Guess I didn't really need to. Thought it would dip to the mid $4's.
This market is so whacked right now!!! Like a yo yo!!!
It certainly had quite the interest when it was running gapping up and running over $4 with almost 250 million shares traded. Add all that action with a float just around 30 million and it looks impressive. Stock with small floats that get this kind of attention trading their float multiple times over brings in the day traders big time. I was in and out fairly quickly myself.
Then I like to see if there's any meat on the bone worth hanging around for when the dust settles for a longer, more solid position. It takes time for a stock to settle, especially after being pumped like this one was. Don't get me wrong, had Red Cat disclosed the details of the NASA deal this may have found a new base pricing in the deal. But, did we see any such details? Nope. So, when I saw that the CFO was trading in his options and holding the shares, I found that interesting. But it appeared that the market (and long time shareholders) didn't even flinch. So I put this back on my watchlist to see if the gap fills around 2.40 And I'll keep an eye on it as well. Best of luck to you, maybe I'll be back in this one soon. I'm more of a swing trader than a long term shareholder.
I'm certainly not a professional trader, far from it! I'm more of a technical / chart trader.
Thought I should clarify....
https://www.soligenix.com/pipeline-programs/thermovax/
I didn't want to copy and paste the whole page but there's much more to it. Here's the COVID part...
Coronavirus Vaccines (CiVaxTM)
Coronaviruses are a family of viruses that are known to cause a variety of respiratory infections, with varying symptoms and severity. SARS-CoV-2, the cause of COVID-19, is the most recent example of this family of viruses. These viruses are particularly problematic because of their high transmissibility, resulting in high absolute mortality even with relatively low overall mortality rates.
The key antigen for targeting coronaviruses is believed to be a Spike protein on the viral surface. This protein is also a multimeric (specifically trimeric) glycoprotein. It is therefore very compatible with our existing collaborative program
CiVax™ is a vaccine candidate that combines the Spike protein antigen with the CoVaccine adjuvant. Results to date have indicated strong immunogenicity in mouse models and nonclinical studies are continuing.
Pfizer should be checking out $SNGX imo. Just thinking.
To a great extent we're in our own world (OTC) until IPIX's brilacidin impresses not just big pharma but the whole bio sector. If that happens, we won't be on the otc much longer imo.
Other than that we're just another OTC in the breeze. Sure Leo could have gone a much more toxic funding rout and burred this in so much debt we'd already be in the billions of shares outstanding. Thankfully he didn't. And we're looking at a pipeline that may just have a chance to make its mark. Brilacidin could provide the momentum and funding to move everything forward. Till then, it's all retail and the roll of the dice against all the market manipulation you can think of. As well as the dilution. No conspiracy theories here, IPIX proves itself or it doesn't. So far, we know where we are.
But that's only part of the story isn't it?
It's always been about the potential.
And that's what we're waiting to find out, and likely soon. Bring on the brilacidin data and see IPIX get it's name into the mainstream!!
It could happen.
Message in reply to:
Pete and Boo, thank you for all your efforts to inform and promote IPIX and B. I am in lock step on that. But please explain to me, so I will know too, just how BP is trying to keep our drugs hidden. What are they actively doing. Please be a bit detailed. No conspiracy theories. Thanks guys.
When I saw the CFO's form 4 I wanted to see if RCAT would get any attention.
Interesting it didn't spark any buying.
ATHX 1.33 pincher radar. SONN nice volume yesterday, gap just filled. We'll (I'll) see what she's got.
Watching this dip on SYN too, if history repeats it could sink into the low .30's upper .20's support.
ATHX daily
Volume was really kicking in yesterday. Yes, looking pretty good here. Gap filled and ready to go.
Right now those finding this stock are the luckiest people alive. You didn't have to endure the hard times, stock price is still low enough for true visionaries to acquire a position that should bring about riches, IPIX/Brilacidin/Kevetrin can no longer be kept hidden no matter how hard BP tries to keep them hidden, and the share price should show some real appreciation by the end of the month or shortly thereafter once trial results are announced.
October is a month for stockholders to sit back and wait as our time finally is at hand to see some returns on our investment.
Nicely put Pete!!! Just a bit of patience and this may finally start getting the attention it deserves. More peer review and top dogs talking about IPIX / brilacidin!!
Message in reply to:
I wrote that post in April. How does it stack up against today, 6 months later? BRILACIDIN TODAY LOOKS EVEN STRONGER!!!!
Why?
1. B has been proven in RBL testing to also be effective against unenveloped viruses, thus it should become a target of the DOD as a main drug, if not THE only drug, that could be used to protect troops from all viral and bacterial (remember that to date B has not been tested against any bacteria it could not kill) threats. This is a major funding avenue I expect to come to IPIX after top line results are published.
The above paragraph is a major arm in showing how broad spectrum based is Brilacidin.
2. ALL other Covid vaccines and treatments have shown no ability to aid those patients with anything worse than beginning symptoms of the drugs and must be given very early in the medical cycle to be even somewhat efficient. B will be showing that it can work even on those with much further advanced cases to include very severe symptoms should the Compassionate Use patient stories prove true as to B working on patients 5 to 10 times worse off than those tested in our P2 trial.
3. Broad spectrum -Cannot stress this enough. So far B has shown itself (in RBL testing, not IPIX testing) to be effective or probably effective once RBLs have done further testing against all Covid viruses, many other lines of viruses to include filo viruses (Ebola and Marburg), bacteria, all issues in the GI tract, kidney problems, liver problems, encephalitis, inflammatory lung issues that could include COPD, Asthma, and Bronchitis, and even possibly leaky gut (which leads to leaky brain) and this could result in a possible treatment for ALS (Lou Gehrig's disease), Parkinson's disease, dementia, and even Alzheimer's. Not saying anything finalized yet on the above but testing to date would lead one to believe many of these could come about. Look at the history of B and to date anything thought possible has come to fruition so the future for Brilacidin is so much larger for Brilacidin than simply a Covid treatment is why so many longs are giddy for our future fortunes and for the many sufferers in the world of all these tragic conditions. I have heard it said that to date they have only scratched the surface in regards to the many medical and non-medical uses of Brilacidin. Could one day Brilacidin become a pill, spray, or the like that everybody worldwide would take on a daily or regular basis to protect themselves against a widespread band of dangerous conditions? Sounds far-fetched but so did many of the things we saw in the old time Dick Tracy comic strip and they all have come true. No reason Brilacidin won't become the "penicillin" of the 21st century. Think about it; safe, effective, and not expensive to manufacture. Of course, it would wipe out trillions of dollars per year on worldwide medical costs so one can see why many might not be that happy to see such a wonderful product come to full fruition.
4. Sound too good to be true for a mere penny stock? Will not go into the financial history that has kept IPIX share price at these absurdly low levels, do your own DD and you will find that to this point in time (as a startup biotech) the money just wasn't there to advance Brilacidin and Kevetrin any faster than has been done. But all that stops once we get positive trial results and a number of research grants become available to IPIX.
Right now those finding this stock are the luckiest people alive. You didn't have to endure the hard times, stock price is still low enough for true visionaries to acquire a position that should bring about riches, IPIX/Brilacidin/Kevetrin can no longer be kept hidden no matter how hard BP tries to keep them hidden, and the share price should show some real appreciation by the end of the month or shortly thereafter once trial results are announced.
October is a month for stockholders to sit back and wait as our time finally is at hand to see some returns on our investment.
Even more important, Covid should become a fear of the past for most of the world.
STRONG BUY $11 TARGET
https://www.nasdaq.com/market-activity/stocks/eyeg/analyst-research
I'm not the one making this up. Just a disclaimer. And I try and take the volatility of an entity into account after they do the sin of all stocks by doing a reverse split. The float is so small it can skyrocket and still close red in the same day. With something solid this may have a chance. Maybe their upcoming data will provide the catalyst.
GLTA $EYEG
Yes, I bought 1.85 and did do a quick swing here the other day premarket (Oct 1st) thought it would have more gusto. It may.
Strong buy, $3 target.
https://www.nasdaq.com/market-activity/stocks/dynt/analyst-research
Keep an eye on this puppy. I'm seeing the potential for a few analyst upgrades.
https://finviz.com/quote.ashx?t=DYNT
10-K
https://www.sec.gov/Archives/edgar/data/720875/000165495421010318/dynt10k2021.htm
1.85 looks good to me. $$$ boogie time tomorrow maybe!
Back over $2 and on its way to 3. RIIIIP IT!!!
Not at all. When I ate some in the .20's last Friday I like to keep an eye on the charts to see IF I chose wisely.
So far, so good. Though the chunk I ate at .26 is down slightly.
Good 'ole markets eh?
Just bring on the data and make us RICH and SAVE SOME LIVES!!!!
Todays low of .2016 is still a higher low by .0016.
Possibly the bottom of .20 will hold for the rebound into the .30's. Decent data and this may be on its way to the $$$$ land.
Just being patient now.
Rough day out there today for the markets. This can float on air easy enough with the small float it has.
This could get interesting.
Let's see the volume kick in! https://finance.yahoo.com/news/contrafect-phase-2-exebacase-data-130000870.html
Love seeing a plan turn to action!!! Nice early volume!!
Go $$$$SONN!
And the selling continues as I thought it would. Taking advantage of over pricing is just a natural thing imo. Once this is back around 2.50 - 3 I think we'll see them getting their shares back. I will be anyway. But then, if they showed constraint 1.e. patience (not selling), it would show a lot more faith in their own science.
https://ih.advfn.com/stock-market/NASDAQ/corvus-pharmaceuticals-CRVS/stock-news/86197328/statement-of-changes-in-beneficial-ownership-4